| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A Novel Approach to Medical Management of Heart Failure With Reduced Ejection Fraction
|
Miller, Robert J.H.
|
|
|
37 |
4 |
p. 632-643
|
artikel
|
| 2 |
Cardiomyopathies and Genetic Testing in Heart Failure: Role in Defining Phenotype-Targeted Approaches and Management
|
Yogasundaram, Haran
|
|
|
37 |
4 |
p. 547-559
|
artikel
|
| 3 |
Cardiovascular Autonomic Disturbances in Heart Failure With Preserved Ejection Fraction
|
Badrov, Mark B.
|
|
|
37 |
4 |
p. 609-620
|
artikel
|
| 4 |
CCS/CHFS Heart Failure Guidelines Update: Defining a New Pharmacologic Standard of Care for Heart Failure With Reduced Ejection Fraction
|
McDonald, Michael
|
|
|
37 |
4 |
p. 531-546
|
artikel
|
| 5 |
Cyclin-Dependent Kinase Inhibitor 2b Controls Fibrosis and Functional Changes in Ischemia-Induced Heart Failure via the BMI1-p15-Rb Signalling Pathway
|
Yang, Wenbo
|
|
|
37 |
4 |
p. 655-664
|
artikel
|
| 6 |
Editorial Board
|
|
|
|
37 |
4 |
p. A1-A2
|
artikel
|
| 7 |
Establishing a Cardiac Amyloidosis Clinic: A Practical Primer for Cardiologists
|
Davis, Margot K.
|
|
|
37 |
4 |
p. 674-678
|
artikel
|
| 8 |
Evidence-Based Management of Acute Heart Failure
|
Gupta, Arjun K.
|
|
|
37 |
4 |
p. 621-631
|
artikel
|
| 9 |
Heart Failure With Midrange Ejection Fraction—What Is It, If Anything?
|
Boulet, Jacinthe
|
|
|
37 |
4 |
p. 585-594
|
artikel
|
| 10 |
How Diabetes and Heart Failure Modulate Each Other and Condition Management
|
Randhawa, Varinder Kaur
|
|
|
37 |
4 |
p. 595-608
|
artikel
|
| 11 |
Information for Readers
|
|
|
|
37 |
4 |
p. A6
|
artikel
|
| 12 |
Positive Recommendation for Angiotensin Receptor–Neprilysin Inhibitor: First Medication Approval for Heart Failure Without Reduced Ejection Fraction
|
Howlett, Jonathan G.
|
|
|
37 |
4 |
p. 528-530
|
artikel
|
| 13 |
President’s Page
|
Ruel, Dr Marc
|
|
|
37 |
4 |
p. 525-527
|
artikel
|
| 14 |
Pulmonary Hypertension Due to Left Heart Disease—A Practical Approach to Diagnosis and Management
|
Lee, Felicity
|
|
|
37 |
4 |
p. 572-584
|
artikel
|
| 15 |
Sex-Specific Differences in Heart Failure: Pathophysiology, Risk Factors, Management, and Outcomes
|
Sullivan, Kristen
|
|
|
37 |
4 |
p. 560-571
|
artikel
|
| 16 |
Shared Decision Making and Effective Communication in Heart Failure—Moving from “Code Status” to Decisional Readiness
|
McGuinty, Caroline
|
|
|
37 |
4 |
p. 665-668
|
artikel
|
| 17 |
Table of Contents
|
|
|
|
37 |
4 |
p. A3-A5
|
artikel
|
| 18 |
The Optimal Timing of Primary Prevention Implantable Cardioverter-Defibrillator Referral in the Rapidly Changing Medical Landscape
|
Wong, Jorge A.
|
|
|
37 |
4 |
p. 644-654
|
artikel
|
| 19 |
When and How to Use Sodium-Glucose Cotransporter 2 Inhibitors in Patients With Heart Failure With Reduced Ejection Fraction or Chronic Kidney Disease
|
O’Meara, Eileen
|
|
|
37 |
4 |
p. 669-673
|
artikel
|
Tijdschrift beschrijving